List of Tables
Table 1. Global Adrenoleukodystrophy Treatment Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Oral Drugs
Table 3. Key Players of Parenteral Drugs
Table 4. Global Adrenoleukodystrophy Treatment Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 5. Global Adrenoleukodystrophy Treatment Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Adrenoleukodystrophy Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Adrenoleukodystrophy Treatment Market Share by Region (2018-2023)
Table 8. Global Adrenoleukodystrophy Treatment Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global Adrenoleukodystrophy Treatment Market Share by Region (2024-2029)
Table 10. Adrenoleukodystrophy Treatment Market Trends
Table 11. Adrenoleukodystrophy Treatment Market Drivers
Table 12. Adrenoleukodystrophy Treatment Market Challenges
Table 13. Adrenoleukodystrophy Treatment Market Restraints
Table 14. Global Adrenoleukodystrophy Treatment Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Adrenoleukodystrophy Treatment Market Share by Players (2018-2023)
Table 16. Global Top Adrenoleukodystrophy Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Adrenoleukodystrophy Treatment as of 2022)
Table 17. Ranking of Global Top Adrenoleukodystrophy Treatment Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Adrenoleukodystrophy Treatment Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Adrenoleukodystrophy Treatment Product Solution and Service
Table 21. Date of Enter into Adrenoleukodystrophy Treatment Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Adrenoleukodystrophy Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Adrenoleukodystrophy Treatment Revenue Market Share by Type (2018-2023)
Table 25. Global Adrenoleukodystrophy Treatment Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global Adrenoleukodystrophy Treatment Revenue Market Share by Type (2024-2029)
Table 27. Global Adrenoleukodystrophy Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Adrenoleukodystrophy Treatment Revenue Market Share by Application (2018-2023)
Table 29. Global Adrenoleukodystrophy Treatment Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global Adrenoleukodystrophy Treatment Revenue Market Share by Application (2024-2029)
Table 31. North America Adrenoleukodystrophy Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 32. North America Adrenoleukodystrophy Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Adrenoleukodystrophy Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 34. Europe Adrenoleukodystrophy Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. Europe Adrenoleukodystrophy Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Adrenoleukodystrophy Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 37. Asia-Pacific Adrenoleukodystrophy Treatment Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 38. Asia-Pacific Adrenoleukodystrophy Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Adrenoleukodystrophy Treatment Market Size by Region (2024-2029) & (US$ Million)
Table 40. Latin America Adrenoleukodystrophy Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 41. Latin America Adrenoleukodystrophy Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Adrenoleukodystrophy Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 43. Middle East & Africa Adrenoleukodystrophy Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Middle East & Africa Adrenoleukodystrophy Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Adrenoleukodystrophy Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 46. bluebird bio Company Detail
Table 47. bluebird bio Business Overview
Table 48. bluebird bio Adrenoleukodystrophy Treatment Product
Table 49. bluebird bio Revenue in Adrenoleukodystrophy Treatment Business (2018-2023) & (US$ Million)
Table 50. bluebird bio Recent Development
Table 51. Orpheris Company Detail
Table 52. Orpheris Business Overview
Table 53. Orpheris Adrenoleukodystrophy Treatment Product
Table 54. Orpheris Revenue in Adrenoleukodystrophy Treatment Business (2018-2023) & (US$ Million)
Table 55. Orpheris Recent Development
Table 56. MedDay Pharmaceuticals Company Detail
Table 57. MedDay Pharmaceuticals Business Overview
Table 58. MedDay Pharmaceuticals Adrenoleukodystrophy Treatment Product
Table 59. MedDay Pharmaceuticals Revenue in Adrenoleukodystrophy Treatment Business (2018-2023) & (US$ Million)
Table 60. MedDay Pharmaceuticals Recent Development
Table 61. MINORYX THERAPEUTICS SL Company Detail
Table 62. MINORYX THERAPEUTICS SL Business Overview
Table 63. MINORYX THERAPEUTICS SL Adrenoleukodystrophy Treatment Product
Table 64. MINORYX THERAPEUTICS SL Revenue in Adrenoleukodystrophy Treatment Business (2018-2023) & (US$ Million)
Table 65. MINORYX THERAPEUTICS SL Recent Development
Table 66. Pfizer Company Detail
Table 67. Pfizer Business Overview
Table 68. Pfizer Adrenoleukodystrophy Treatment Product
Table 69. Pfizer Revenue in Adrenoleukodystrophy Treatment Business (2018-2023) & (US$ Million)
Table 70. Pfizer Recent Development
Table 71. Amgen Company Detail
Table 72. Amgen Business Overview
Table 73. Amgen Adrenoleukodystrophy Treatment Product
Table 74. Amgen Revenue in Adrenoleukodystrophy Treatment Business (2018-2023) & (US$ Million)
Table 75. Amgen Recent Development
Table 76. AstraZeneca Company Detail
Table 77. AstraZeneca Business Overview
Table 78. AstraZeneca Adrenoleukodystrophy Treatment Product
Table 79. AstraZeneca Revenue in Adrenoleukodystrophy Treatment Business (2018-2023) & (US$ Million)
Table 80. AstraZeneca Recent Development
Table 81. Abbott Company Detail
Table 82. Abbott Business Overview
Table 83. Abbott Adrenoleukodystrophy Treatment Product
Table 84. Abbott Revenue in Adrenoleukodystrophy Treatment Business (2018-2023) & (US$ Million)
Table 85. Abbott Recent Development
Table 86. agtc Company Detail
Table 87. agtc Business Overview
Table 88. agtc Adrenoleukodystrophy Treatment Product
Table 89. agtc Revenue in Adrenoleukodystrophy Treatment Business (2018-2023) & (US$ Million)
Table 90. agtc Recent Development
Table 91. ReceptoPharm Company Detail
Table 92. ReceptoPharm Business Overview
Table 93. ReceptoPharm Adrenoleukodystrophy Treatment Product
Table 94. ReceptoPharm Revenue in Adrenoleukodystrophy Treatment Business (2018-2023) & (US$ Million)
Table 95. ReceptoPharm Recent Development
Table 96. The Myelin Project Company Detail
Table 97. The Myelin Project Business Overview
Table 98. The Myelin Project Adrenoleukodystrophy Treatment Product
Table 99. The Myelin Project Revenue in Adrenoleukodystrophy Treatment Business (2018-2023) & (US$ Million)
Table 100. The Myelin Project Recent Development
Table 101. SOM Biotech Company Detail
Table 102. SOM Biotech Business Overview
Table 103. SOM Biotech Adrenoleukodystrophy Treatment Product
Table 104. SOM Biotech Revenue in Adrenoleukodystrophy Treatment Business (2018-2023) & (US$ Million)
Table 105. SOM Biotech Recent Development
Table 106. Viking Therapeutics Company Detail
Table 107. Viking Therapeutics Business Overview
Table 108. Viking Therapeutics Adrenoleukodystrophy Treatment Product
Table 109. Viking Therapeutics Revenue in Adrenoleukodystrophy Treatment Business (2018-2023) & (US$ Million)
Table 110. Viking Therapeutics Recent Development
Table 111. Nutra Pharma Corporation Company Detail
Table 112. Nutra Pharma Corporation Business Overview
Table 113. Nutra Pharma Corporation Adrenoleukodystrophy Treatment Product
Table 114. Nutra Pharma Corporation Revenue in Adrenoleukodystrophy Treatment Business (2018-2023) & (US$ Million)
Table 115. Nutra Pharma Corporation Recent Development
Table 116. Genetix Biotech Company Detail
Table 117. Genetix Biotech Business Overview
Table 118. Genetix Biotech Adrenoleukodystrophy Treatment Product
Table 119. Genetix Biotech Revenue in Adrenoleukodystrophy Treatment Business (2018-2023) & (US$ Million)
Table 120. Genetix Biotech Recent Development
Table 121. Magenta Therapeutics Company Detail
Table 122. Magenta Therapeutics Business Overview
Table 123. Magenta Therapeutics Adrenoleukodystrophy Treatment Product
Table 124. Magenta Therapeutics Revenue in Adrenoleukodystrophy Treatment Business (2018-2023) & (US$ Million)
Table 125. Magenta Therapeutics Recent Development
Table 126. NeuroVia Company Detail
Table 127. NeuroVia Business Overview
Table 128. NeuroVia Adrenoleukodystrophy Treatment Product
Table 129. NeuroVia Revenue in Adrenoleukodystrophy Treatment Business (2018-2023) & (US$ Million)
Table 130. NeuroVia Recent Development
Table 131. Novartis Company Detail
Table 132. Novartis Business Overview
Table 133. Novartis Adrenoleukodystrophy Treatment Product
Table 134. Novartis Revenue in Adrenoleukodystrophy Treatment Business (2018-2023) & (US$ Million)
Table 135. Novartis Recent Development
Table 136. CELGENE CORPORATION Company Detail
Table 137. CELGENE CORPORATION Business Overview
Table 138. CELGENE CORPORATION Adrenoleukodystrophy Treatment Product
Table 139. CELGENE CORPORATION Revenue in Adrenoleukodystrophy Treatment Business (2018-2023) & (US$ Million)
Table 140. CELGENE CORPORATION Recent Development
Table 141. Jazz Pharmaceuticals Company Detail
Table 142. Jazz Pharmaceuticals Business Overview
Table 143. Jazz Pharmaceuticals Adrenoleukodystrophy Treatment Product
Table 144. Jazz Pharmaceuticals Revenue in Adrenoleukodystrophy Treatment Business (2018-2023) & (US$ Million)
Table 145. Jazz Pharmaceuticals Recent Development
Table 146. Sanofi Company Detail
Table 147. Sanofi Business Overview
Table 148. Sanofi Adrenoleukodystrophy Treatment Product
Table 149. Sanofi Revenue in Adrenoleukodystrophy Treatment Business (2018-2023) & (US$ Million)
Table 150. Sanofi Recent Development
Table 151. Research Programs/Design for This Report
Table 152. Key Data Information from Secondary Sources
Table 153. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Adrenoleukodystrophy Treatment Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Adrenoleukodystrophy Treatment Market Share by Type: 2022 VS 2029
Figure 3. Oral Drugs Features
Figure 4. Parenteral Drugs Features
Figure 5. Global Adrenoleukodystrophy Treatment Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 6. Global Adrenoleukodystrophy Treatment Market Share by Application: 2022 VS 2029
Figure 7. Hospital Case Studies
Figure 8. Clinic Case Studies
Figure 9. Home Care Case Studies
Figure 10. Adrenoleukodystrophy Treatment Report Years Considered
Figure 11. Global Adrenoleukodystrophy Treatment Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 12. Global Adrenoleukodystrophy Treatment Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Adrenoleukodystrophy Treatment Market Share by Region: 2022 VS 2029
Figure 14. Global Adrenoleukodystrophy Treatment Market Share by Players in 2022
Figure 15. Global Top Adrenoleukodystrophy Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Adrenoleukodystrophy Treatment as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Adrenoleukodystrophy Treatment Revenue in 2022
Figure 17. North America Adrenoleukodystrophy Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 18. North America Adrenoleukodystrophy Treatment Market Share by Country (2018-2029)
Figure 19. United States Adrenoleukodystrophy Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. Canada Adrenoleukodystrophy Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Europe Adrenoleukodystrophy Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Europe Adrenoleukodystrophy Treatment Market Share by Country (2018-2029)
Figure 23. Germany Adrenoleukodystrophy Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. France Adrenoleukodystrophy Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. U.K. Adrenoleukodystrophy Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Italy Adrenoleukodystrophy Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Russia Adrenoleukodystrophy Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Nordic Countries Adrenoleukodystrophy Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Asia-Pacific Adrenoleukodystrophy Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Asia-Pacific Adrenoleukodystrophy Treatment Market Share by Region (2018-2029)
Figure 31. China Adrenoleukodystrophy Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Japan Adrenoleukodystrophy Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. South Korea Adrenoleukodystrophy Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Southeast Asia Adrenoleukodystrophy Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. India Adrenoleukodystrophy Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Australia Adrenoleukodystrophy Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Latin America Adrenoleukodystrophy Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Latin America Adrenoleukodystrophy Treatment Market Share by Country (2018-2029)
Figure 39. Mexico Adrenoleukodystrophy Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Brazil Adrenoleukodystrophy Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Middle East & Africa Adrenoleukodystrophy Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Middle East & Africa Adrenoleukodystrophy Treatment Market Share by Country (2018-2029)
Figure 43. Turkey Adrenoleukodystrophy Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Saudi Arabia Adrenoleukodystrophy Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. bluebird bio Revenue Growth Rate in Adrenoleukodystrophy Treatment Business (2018-2023)
Figure 46. Orpheris Revenue Growth Rate in Adrenoleukodystrophy Treatment Business (2018-2023)
Figure 47. MedDay Pharmaceuticals Revenue Growth Rate in Adrenoleukodystrophy Treatment Business (2018-2023)
Figure 48. MINORYX THERAPEUTICS SL Revenue Growth Rate in Adrenoleukodystrophy Treatment Business (2018-2023)
Figure 49. Pfizer Revenue Growth Rate in Adrenoleukodystrophy Treatment Business (2018-2023)
Figure 50. Amgen Revenue Growth Rate in Adrenoleukodystrophy Treatment Business (2018-2023)
Figure 51. AstraZeneca Revenue Growth Rate in Adrenoleukodystrophy Treatment Business (2018-2023)
Figure 52. Abbott Revenue Growth Rate in Adrenoleukodystrophy Treatment Business (2018-2023)
Figure 53. agtc Revenue Growth Rate in Adrenoleukodystrophy Treatment Business (2018-2023)
Figure 54. ReceptoPharm Revenue Growth Rate in Adrenoleukodystrophy Treatment Business (2018-2023)
Figure 55. The Myelin Project Revenue Growth Rate in Adrenoleukodystrophy Treatment Business (2018-2023)
Figure 56. SOM Biotech Revenue Growth Rate in Adrenoleukodystrophy Treatment Business (2018-2023)
Figure 57. Viking Therapeutics Revenue Growth Rate in Adrenoleukodystrophy Treatment Business (2018-2023)
Figure 58. Nutra Pharma Corporation Revenue Growth Rate in Adrenoleukodystrophy Treatment Business (2018-2023)
Figure 59. Genetix Biotech Revenue Growth Rate in Adrenoleukodystrophy Treatment Business (2018-2023)
Figure 60. Magenta Therapeutics Revenue Growth Rate in Adrenoleukodystrophy Treatment Business (2018-2023)
Figure 61. NeuroVia Revenue Growth Rate in Adrenoleukodystrophy Treatment Business (2018-2023)
Figure 62. Novartis Revenue Growth Rate in Adrenoleukodystrophy Treatment Business (2018-2023)
Figure 63. CELGENE CORPORATION Revenue Growth Rate in Adrenoleukodystrophy Treatment Business (2018-2023)
Figure 64. Jazz Pharmaceuticals Revenue Growth Rate in Adrenoleukodystrophy Treatment Business (2018-2023)
Figure 65. Sanofi Revenue Growth Rate in Adrenoleukodystrophy Treatment Business (2018-2023)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed